A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

PURPOSE: To accurately assess disease progression after Stereotactic Ablative Radiotherapy (SABR) of early-stage Non-Small Cell Lung Cancer (NSCLC), a combined predictive model based on pre-treatment CT radiomics features and clinical factors was established. METHODS: This study retrospectively anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Wang, Lin, Shao, Guoliang, Dong, Baiqiang, Wang, Fang, Wei, Yuguo, Li, Pu, Chen, Haiyan, Chen, Wujie, Zheng, Yao, He, Yiwei, Zhao, Yankun, Du, Xianghui, Sun, Xiaojiang, Wang, Zhun, Wang, Yuezhen, Zhou, Xia, Lai, Xiaojing, Feng, Wei, Shen, Liming, Qiu, Guoqing, Ji, Yongling, Chen, Jianxiang, Jiang, Youhua, Liu, Jinshi, Zeng, Jian, Wang, Changchun, Zhao, Qiang, Yang, Xun, Hu, Xiao, Ma, Honglian, Chen, Qixun, Chen, Ming, Jiang, Haitao, Xu, Yujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380646/
https://www.ncbi.nlm.nih.gov/pubmed/35982975
http://dx.doi.org/10.3389/fonc.2022.967360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380646/
https://www.ncbi.nlm.nih.gov/pubmed/35982975
http://dx.doi.org/10.3389/fonc.2022.967360

Ejemplares similares